Medical nutrition therapy in chronic kidney failure: Integrating clinical practice guidelines

被引：61

作者：

Beto, JA

Bansal, VK

机构：

[1] Dominican Univ, Nutr Serv, River Forest, IL 60305 USA

[2] Loyola Univ, Med Ctr, Div Nephrol & Hypertens, Maywood, IL 60153 USA

来源：

JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION | 2004年 / 104卷 / 03期

关键词：

D O I：

10.1016/j.jada.2003.12.028

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

This review updates earlier published recommendations and integrates current clinical practice guidelines for nutritional care in chronic kidney disease as recommended by the National Kidney Foundation Kidney Dialysis Outcome Quality Initiative (K/DOQI). The scope covers chronic kidney disease in adults prior to kidney failure (Stages 1-4), chronic kidney failure with hemodialysis or peritoneal dialysis replacement therapy (Stage 5), and management after kidney transplantation. Multiple diet parameters are necessary to provide optimal nutritional health, including monitoring of calories, protein, sodium, fluid, potassium, calcium, and phosphorus, as well as other individualized nutrients. Emphasis is placed on continuity of care within changing kidney function and treatment modality status. The rising incidence of chronic kidney disease will increase the probability of the non-renal specialist dietetics professional delivering care to this patient population.

引用

页码：404 / 409

页数：6

共 25 条

[1]

[Anonymous], 2003, American Medical Journal of Kidney Disease, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3

[2]

Beto J, 1992, J RENAL NUTR, V2, P28

[3]

Beto J A, 1998, J Ren Nutr, V8, P21, DOI 10.1016/S1051-2276(98)90033-4

[4] WHICH DIET FOR WHICH RENAL-FAILURE - MAKING SENSE OF THE OPTIONS [J].

BETO, JA .

JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1995, 95 (08) :898-903

[5] Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].

Block, GA ;

Hulbert-Shearon, TE ;

Levin, NW ;

Port, FK .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617

[6] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[7] Excerpts from the United States Renal Data System 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States - Preface [J].

Collins, AJ ;

Kasiske, B ;

Herzog, C ;

Chen, SC ;

Everson, S ;

Constantini, E ;

Grimm, R ;

McBean, M ;

Xue, J ;

Chavers, B ;

Matas, A ;

Manning, W ;

Louis, T ;

Ma, J ;

Pan, W ;

Liu, JN ;

Li, SY ;

Roberts, T ;

Dalleska, F ;

Snyder, J ;

Ebben, J ;

Frazier, E ;

Sheets, D ;

Johnson, R ;

Li, SL ;

Dunning, S ;

Berrini, D ;

Guo, HF ;

Palzer, M ;

Solid, C ;

Arko, C ;

Daniels, F ;

Wang, XY ;

Gilbertson, D ;

St Peter, W ;

Frederick, P ;

Eggers, P ;

Agodoa, L .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :V-IX

[8] Future role of calcimimetics in end-stage renal disease [J].

Goodman, WG ;

Turner, SA .

ADVANCES IN RENAL REPLACEMENT THERAPY, 2002, 9 (03) :200-208

[9]

Hayes C P Jr, 1967, Trans Assoc Am Physicians, V80, P207

[10] Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis [J].

Jafar, TH ;

Stark, PC ;

Schmid, CH ;

Landa, M ;

Maschio, G ;

de Jong, PE ;

de Zeeuw, D ;

Shahinfar, S ;

Toto, R ;

Levey, AS .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (04) :244-252

← 1 2 3 →